A 5 Treatment Period Pharmacokinetic Study Evaluating Dose Proportionality and Food Effects of Diazoxide Choline Controlled-Release Tablet (DCCR)

Inclusion Criteria: * Ability to follow verbal and written instructions * Informed consent form signed by the subject * Completed screening within 7 days prior to dosing * BMI between 18.5 and 35 kg/m2 * Generally healthy * fasting glucose less than or equal to 100 mg/dL * HbA1c less than or equal to 6% Exclusion Criteria: * Pregnancy or breast feeding * absence of contraception * administration of investigational drug within 1 month prior to screening * anticipated requirement for prohibited medication (systemic corticosteroids or anti-diabetic medications) * allergic reaction to or significant intolerance of diazoxide, thiazides or sulfonamides * known type 1 or type 2 diabetes mellitus * congestive heart failure * gastric bypass surgery * history of drug or alcohol abuse